Your browser doesn't support javascript.
loading
Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation.
Bariana, Manpreet; Cassella, Elena; Rateshwar, Janice; Ouk, Samedy; Liou, Hsiou-Chi; Heller, Claudia; Colorado, Iriana; Feinman, Rena; Makhdoom, Ali; Siegel, David S; Heller, Glenn; Tuckett, Andrea; Mondello, Patrizia; Zakrzewski, Johannes L.
Afiliação
  • Bariana M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.
  • Cassella E; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.
  • Rateshwar J; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.
  • Ouk S; ImmuneTarget Inc., San Diego, California.
  • Liou HC; ImmuneTarget Inc., San Diego, California.
  • Heller C; Hackensack Meridian School of Medicine, Nutley, New Jersey.
  • Colorado I; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.
  • Feinman R; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.
  • Makhdoom A; Hackensack Meridian School of Medicine, Nutley, New Jersey.
  • Siegel DS; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.
  • Heller G; Multiple Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.
  • Tuckett A; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mondello P; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zakrzewski JL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Mol Cancer Ther ; 21(12): 1798-1809, 2022 12 02.
Article em En | MEDLINE | ID: mdl-36190955

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article